Hayden Royal’s AbbVie ABBV Stock Holding History

Hayden Royal’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	$524K	Buy	3,873 +554	+17%	+$65.4K	1.23%	14
2021 Q3	$358K	Sell	3,319 -5,498	-62%	-$628K	0.58%	43
2021 Q2	$993K	Buy	8,817 +650	+8%	+$73.2K	0.55%	44
2021 Q1	$884K	Sell	8,167 -113	-1%	-$12.1K	0.51%	52
2020 Q4	$887K	Sell	8,280 -81	-1%	-$7.78K	0.48%	45
2020 Q3	$732K	Buy	8,361 +527	+7%	+$49.6K	0.39%	66
2020 Q2	$769K	Buy	7,834 +2,433	+45%	+$214K	0.43%	56
2020 Q1	$411K	Sell	5,401 -595	-10%	-$50.7K	0.24%	107
2019 Q4	$561K	Sell	5,996 -3,926	-40%	-$326K	0.28%	90
2019 Q3	$749K	Buy	9,922 +4,393	+79%	+$301K	0.66%	49
2019 Q2	$397K	Sell	5,529 -1,250	-18%	-$98.3K	0.42%	77
2019 Q1	$546K	Buy	6,779 +11	+0.2%	+$900	0.71%	47
2018 Q4	$624K	Buy	+6,768	New	+$595K	0.32%	71

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Hayden Royal's ABBV Position: Q4 2021 in Review

Hayden Royal increased its AbbVie (ABBV) stake by 17% in Q4 2021, buying an estimated $65.4K and bringing the position to 3,873 shares worth $524K. The position accounts for 1.23% of the portfolio, ranked #14.

Hayden Royal first reported a position in ABBV in Q4 2018 and has held it in 13 quarters since. The position peaked at $993K in Q2 2021. 2,981 funds tracked by Wall St. Rank hold ABBV as of Q4 2021.

Hayden Royal held 3,873 shares of AbbVie worth $524K as of Q4 2021.
Hayden Royal bought 554 AbbVie shares in Q4 2021, an estimated $65.4K.
AbbVie made up 1.23% of Hayden Royal's portfolio in Q4 2021, its #14 holding.
Hayden Royal first reported a position in AbbVie in Q4 2018 and has held it in 13 quarters since.
Hayden Royal's AbbVie position peaked at $993K in Q2 2021.
2,981 funds tracked by Wall St. Rank held AbbVie as of Q4 2021.

Based on Hayden Royal's 13F filing for Q4 2021, filed 7 Feb 2022.